

Dr Anna Moltó
Dr Anna Moltó is an attending rheumatologist in the Rheumatology Department of Cochin Hospital, Paris, France, and also acts as a clinical researcher in the INSERM ECAMO team (U-1153) from the University of Paris, France.
She completed both her medical studies and rheumatology training at Universitat Autónoma de Barcelona, Spain, in 2010. She completed a clinical research fellowship in Paris, and in 2011, was an assistant professor at Cochin Hospital. Dr Moltó was co-opted by Emerging EULAR Network (EMEUNET) in 2010, where she first served as part of the Country Liaisons subgroup, subsequently as its leader. She was elected Chair of EMEUNET in 2015.
Dr Moltó’s research focuses mainly on the natural history of early axial spondyloarthritis, evaluation of effectiveness in observational trials and pregnancy outcomes in patients with inflammatory rheumatic diseases. She has authored more than 100 peer-reviewed publications.
Explore which treatment targets may be more appropriate for making treatment decisions in axSpA.
PsA and axSpA have overlapping disease manifestations which are driven by inflammation.1 Explore several extracellular cytokines that are implicated in these...
Watch Prof Frank Behrens discuss the importance of treating skin symptoms in addition to musculoskeletal symptoms for patients with SpA.
Achieving ACR50 is associated with improvements in quality of life for patients with PsA.1 Dive into the data supporting higher treatment targets in clinical...
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...